160 results
DEFA14A
PACB
Pacific Biosciences of California Inc
29 Apr 24
Additional proxy soliciting materials
8:17am
Statement
☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐Definitive Proxy Statement
☒Definitive Additional Materials
☐ … of Filing Fee (Check the appropriate box):
☒No fee required
☐Fee paid previously with preliminary materials
☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
8-K
EX-99.1
PACB
Pacific Biosciences of California Inc
16 Apr 24
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
8:08am
in the supply of components or materials for, or manufacturing of, PacBio products and products under development; potential product performance
8-K
EX-99.1
7vlekb2g
15 Feb 24
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
4:07pm
8-K
EX-99.1
rx1bt5pf8ai
30 Oct 23
PacBio Announces Third Quarter 2023 Financial Results
4:06pm
D
i0vxjegqht 4fgdiv
19 Oct 23
$84.76 mm in equity, sold $84.76 mm, 165 investors
4:10pm
D
1r29j7cvtcqglzi7wm8
17 Aug 23
$85.00 mm in equity, sold $85.00 mm, 47 investors
3:52pm
8-K
EX-99.1
cxu qtwr8exj4p
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
SD
EX-1.01
bh6we2jqpiip4qtw4dy
24 May 23
Conflict minerals disclosure
12:00am
8-K
EX-99.1
2xoga49hdeqeb33tx1
2 May 23
PacBio Announces Record Revenue in First Quarter 2023
4:03pm
DEFA14A
fmcbg
13 Apr 23
Additional proxy soliciting materials
4:06pm